<html>
<head>
<title>African genomics startup 54gene raises $15M led by Adjuvant Capital • TechCrunch</title>
<link href="../Styles/Style.css" type="text/css" rel="stylesheet"/>
</head>
<body>
<h1 class="translated">非洲基因组学初创公司54gene融资1500万美元，由辅助资本TechCrunch领投</h1>
<blockquote>原文：<a href="https://web.archive.org/web/https://techcrunch.com/2020/04/14/african-genomics-startup-54gene-raises-15m-led-by-adjuvant-capital/?guccounter=1&amp;guce_referrer=aHR0cHM6Ly93d3cuYmluZy5jb20v&amp;guce_referrer_sig=AQAAACkmYFWDuqgBafNXLPrZpXxAZYsyZCQTnr3RifV0tEwQ16HqW_pHnY3EqBzIn7531mobqwiraatey2igoHN4FD3RQgmSiYIq6Y54pXwnf9vGey4d-Bs9NqcgMC_kJjlv02UVG925sM3-0zqpQ_r5JZdRPJhlCGCm3kTqDvka_eXS">https://web.archive.org/web/https://techcrunch.com/2020/04/14/african-genomics-startup-54gene-raises-15m-led-by-adjuvant-capital/?guccounter=1&amp;guce_referrer=aHR0cHM6Ly93d3cuYmluZy5jb20v&amp;guce_referrer_sig=AQAAACkmYFWDuqgBafNXLPrZpXxAZYsyZCQTnr3RifV0tEwQ16HqW_pHnY3EqBzIn7531mobqwiraatey2igoHN4FD3RQgmSiYIq6Y54pXwnf9vGey4d-Bs9NqcgMC_kJjlv02UVG925sM3-0zqpQ_r5JZdRPJhlCGCm3kTqDvka_eXS</a></blockquote><div><div class="article-content">
				<p id="speakable-summary" class="translated">非洲基因组数据的更大可用性可以为非洲大陆的12亿人口带来医学突破。</p>
<p class="translated">这就是总部位于美国和尼日利亚的初创公司<a href="https://web.archive.org/web/20230120163322/https://www.54gene.com/"> 54gene </a>的推动主张，该公司收集非洲遗传密码，用于健康研究和药物开发。</p>
<p class="translated">该公司已经完成了1500万美元的首轮融资，部分是为了解决这些流程中的一个缺陷。</p>
<p class="translated">“截至我们启动之时，全球所有全基因组关联研究中只有不到3%是在非洲进行的。缺乏来自非洲人和散居者的数据，”54gene创始人兼<a href="https://web.archive.org/web/20230120163322/https://www.linkedin.com/in/abasieneobong/">首席执行官Abasi Ene-Obong博士</a>说。</p>
<p class="translated">“我们正在努力解决目前非洲大陆人民在精准医疗方面存在的差距，”他在拉各斯的一次电话会议上告诉TechCrunch。</p>
<p class="translated">总部设在纽约的佐剂资本领导了第54轮基因现在将部署朝着这一目标。该公司由Ene-Obong于2019年成立，总部位于DC华盛顿州，在拉格斯设有一个生物库设施，可容纳60，000份样本。这家初创公司有一个工程团队和一个专有平台来编目和分析基因数据。</p>
<p/><div id="attachment_1973933" class="wp-caption alignnone"><img aria-describedby="caption-attachment-1973933" decoding="async" loading="lazy" class="wp-image-1973933 size-full" src="../Images/7934ae4518f5cc81a4fef3c05a271385.png" alt="" srcset="https://web.archive.org/web/20230120163322im_/https://techcrunch.com/wp-content/uploads/2020/04/Series-A-photo-1_HighRes-1-1.jpg 3259w, https://web.archive.org/web/20230120163322im_/https://techcrunch.com/wp-content/uploads/2020/04/Series-A-photo-1_HighRes-1-1.jpg?resize=142,150 142w, https://web.archive.org/web/20230120163322im_/https://techcrunch.com/wp-content/uploads/2020/04/Series-A-photo-1_HighRes-1-1.jpg?resize=285,300 285w, https://web.archive.org/web/20230120163322im_/https://techcrunch.com/wp-content/uploads/2020/04/Series-A-photo-1_HighRes-1-1.jpg?resize=768,809 768w, https://web.archive.org/web/20230120163322im_/https://techcrunch.com/wp-content/uploads/2020/04/Series-A-photo-1_HighRes-1-1.jpg?resize=645,680 645w, https://web.archive.org/web/20230120163322im_/https://techcrunch.com/wp-content/uploads/2020/04/Series-A-photo-1_HighRes-1-1.jpg?resize=1458,1536 1458w, https://web.archive.org/web/20230120163322im_/https://techcrunch.com/wp-content/uploads/2020/04/Series-A-photo-1_HighRes-1-1.jpg?resize=1944,2048 1944w, https://web.archive.org/web/20230120163322im_/https://techcrunch.com/wp-content/uploads/2020/04/Series-A-photo-1_HighRes-1-1.jpg?resize=1139,1200 1139w, https://web.archive.org/web/20230120163322im_/https://techcrunch.com/wp-content/uploads/2020/04/Series-A-photo-1_HighRes-1-1.jpg?resize=47,50 47w" sizes="(max-width: 3259px) 100vw, 3259px" data-original-src="https://web.archive.org/web/20230120163322im_/https://techcrunch.com/wp-content/uploads/2020/04/Series-A-photo-1_HighRes-1-1.jpg"/><p id="caption-attachment-1973933" class="wp-caption-text translated">图片来源:54基因</p></div><p class="piano-inline-promo"/>
<p class="translated">54gene在非洲大陆还有300多名研究人员、临床医生和遗传学家，在尼日利亚还有一个研究实验室。</p>
<p class="translated">有了这1500万美元——这使总风险投资达到1950万美元——这家初创公司将把生物银行的能力扩大到20万个样本，长期目标是管理多达50万个样本。54gene也在提升其实验室能力。“有了这笔资金，我们将扩大实验室，这样我们就可以处理成千上万人的实际基因数据，”Ene-Obong说。</p>
<p class="translated">54gene计划在整个组织内进行招聘，从寻找新的财务副总裁到增加额外的科学家。</p>
<p class="translated">该公司通过在医院等场所的研究招募非洲的研究参与者，通过拭子或血液测试采集基因样本。“参与者必须在任何测试前向我们提供知情同意书，”Ene-Obong解释道。</p>
<p class="translated">辅助资本管理合伙人<a href="https://web.archive.org/web/20230120163322/https://www.linkedin.com/in/jenny-yip-08793126/"> Jenny Yip </a>证实了风投公司在1500万美元投资中的领先地位。除了来自佐剂的资金——它本身得到了比尔和梅林达盖茨基金会和诺华的支持——54 gene是2019年Y Combinator 的校友，并获得了硅谷加速器的后续资金。</p>
<p class="translated">该公司有一个更长的收入时间范围，但收入的主要途径是与制药公司合作开发药物和药品。Ene-Obong说:“当这种药物进入市场……并获得批准，54gene和制药公司将分享收入。</p>
<p class="translated">当谈到非洲的救命疗法时，大型制药公司在几十年前就受到了批评。主要的摩擦点是:该行业坚持严格的知识产权执法和非洲大陆艾滋病相关治疗的高利润价格。这导致制药公司和南非政府就该国允许生产这些药物的更便宜的仿制药展开法律斗争。</p>
<p class="translated">关于非洲制药业的价值，麦肯锡咨询公司估计大约为<a href="https://web.archive.org/web/20230120163322/https://www.mckinsey.com/industries/public-sector/our-insights/should-sub-saharan-africa-make-its-own-drugs">140亿美元</a>，远远低于其潜力——考虑到12亿人的新药潜在市场。</p>
<p class="translated">54gene的首席执行官Abasi Ene-Obong明确表示，该公司是一家盈利实体，但其目标是在赚钱动机(和制药合作伙伴的动机)与促进非洲健康之间取得平衡。</p>
<p class="translated">这家初创公司计划通过合作开发药物的做法，对定价过程施加影响。</p>
<p/><div id="attachment_1974016" class="wp-caption alignnone"><img aria-describedby="caption-attachment-1974016" decoding="async" loading="lazy" class="wp-image-1974016 size-full" src="../Images/db63a34772df76d7a21077a9205002b9.png" alt="" srcset="https://web.archive.org/web/20230120163322im_/https://techcrunch.com/wp-content/uploads/2020/04/Dr-Abasi-Ene-Obong-CEO-Founder-54gene_HighRes-1.jpg 5782w, https://web.archive.org/web/20230120163322im_/https://techcrunch.com/wp-content/uploads/2020/04/Dr-Abasi-Ene-Obong-CEO-Founder-54gene_HighRes-1.jpg?resize=148,150 148w, https://web.archive.org/web/20230120163322im_/https://techcrunch.com/wp-content/uploads/2020/04/Dr-Abasi-Ene-Obong-CEO-Founder-54gene_HighRes-1.jpg?resize=296,300 296w, https://web.archive.org/web/20230120163322im_/https://techcrunch.com/wp-content/uploads/2020/04/Dr-Abasi-Ene-Obong-CEO-Founder-54gene_HighRes-1.jpg?resize=768,778 768w, https://web.archive.org/web/20230120163322im_/https://techcrunch.com/wp-content/uploads/2020/04/Dr-Abasi-Ene-Obong-CEO-Founder-54gene_HighRes-1.jpg?resize=671,680 671w, https://web.archive.org/web/20230120163322im_/https://techcrunch.com/wp-content/uploads/2020/04/Dr-Abasi-Ene-Obong-CEO-Founder-54gene_HighRes-1.jpg?resize=1516,1536 1516w, https://web.archive.org/web/20230120163322im_/https://techcrunch.com/wp-content/uploads/2020/04/Dr-Abasi-Ene-Obong-CEO-Founder-54gene_HighRes-1.jpg?resize=2021,2048 2021w, https://web.archive.org/web/20230120163322im_/https://techcrunch.com/wp-content/uploads/2020/04/Dr-Abasi-Ene-Obong-CEO-Founder-54gene_HighRes-1.jpg?resize=1184,1200 1184w, https://web.archive.org/web/20230120163322im_/https://techcrunch.com/wp-content/uploads/2020/04/Dr-Abasi-Ene-Obong-CEO-Founder-54gene_HighRes-1.jpg?resize=32,32 32w, https://web.archive.org/web/20230120163322im_/https://techcrunch.com/wp-content/uploads/2020/04/Dr-Abasi-Ene-Obong-CEO-Founder-54gene_HighRes-1.jpg?resize=50,50 50w, https://web.archive.org/web/20230120163322im_/https://techcrunch.com/wp-content/uploads/2020/04/Dr-Abasi-Ene-Obong-CEO-Founder-54gene_HighRes-1.jpg?resize=64,64 64w, https://web.archive.org/web/20230120163322im_/https://techcrunch.com/wp-content/uploads/2020/04/Dr-Abasi-Ene-Obong-CEO-Founder-54gene_HighRes-1.jpg?resize=96,96 96w" sizes="(max-width: 5782px) 100vw, 5782px" data-original-src="https://web.archive.org/web/20230120163322im_/https://techcrunch.com/wp-content/uploads/2020/04/Dr-Abasi-Ene-Obong-CEO-Founder-54gene_HighRes-1.jpg"/><p id="caption-attachment-1974016" class="wp-caption-text translated">阿巴希·伊娜·奥邦博士，图像鸣谢:54gene</p></div>
<p class="translated">“当你是大型制药公司的服务提供商时，你不可能真的提出这样的要求。但是，当你是一个发展伙伴时，你就共同拥有正在开发的东西的重要股份，并有更多的发言权，”Ene-Obong说。</p>
<p class="translated">这家初创公司无法透露目前任何大型制药公司的合作伙伴，也无法透露它打算通过基因研究来解决非洲的哪些健康问题。</p>
<p class="translated">“我可以说，我们将优先考虑严重影响非洲人的疾病，”Ene-Obong说。</p>
<p class="translated">一种明显需要更有效预防和治疗的疾病是疟疾——根据<a href="https://web.archive.org/web/20230120163322/https://www.afro.who.int/health-topics/malaria">世卫组织的数据</a>，全球2 . 19亿病例中有92%发生在非洲。</p>

<p class="translated">54gene还将其能力转向了新冠肺炎，自3月中旬以来，该公司在非洲的销量激增。该公司已经重新定位，在尼日利亚的公共卫生设施中进行病毒测试，并计划很快在其拉各斯实验室提供冠状病毒筛查。</p>
<p class="translated">“我们希望获得批准后，我们可以每天进行3000次以上的测试，”Ene-Obong说</p>
<p class="translated"><a href="https://web.archive.org/web/20230120163322/https://techcrunch.com/pages/covid-19-updates/"><img decoding="async" src="../Images/04d62e2b241f87e0e899edda87cda169.png" data-original-src="https://web.archive.org/web/20230120163322im_/https://techcrunch.com/wp-content/uploads/2020/03/covid-19-footer.png"/>T2】</a></p>
			</div>

			</div>    
</body>
</html>